The optimal number of lymph nodes examined for rectal cancer patients undergoing neoadjuvant long-course chemoradiotherapy
Journal of Gastrointestinal Oncology · 2025-12 · 16 (6) · 2620-2631
DOI: 10.21037/jgo-2025-463 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Gastrointestinal Oncology, 2025-12. Verfasst von Kexing Xi und 6 weiteren Autor:innen. Beteiligte Einrichtung: Department of Colorectal Surgery, National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital, Chinese Academy of Medical Sci…. Die Arbeit wurde bisher 1-mal zitiert (Crossref). Der Volltext ist frei in PubMed Central verfügbar.
Themen: Onkologische Pflege
Abstract (Originalsprache)
Background
Numerous studies have documented a reduction in the number of lymph nodes (LNs) examined and the number of metastatic LNs in rectal cancer patients as a consequence of neoadjuvant chemoradiotherapy (NCRT). It is plausible that the current guidelines advocating a specific number of LNs to be examined in rectal cancer surgery may be inappropriate for patients undergoing neoadjuvant therapy. This study aimed to determine the optimal number of LNs to be examined in rectal cancer patients treated with NCRT.
Methods
We conducted a retrospective analysis of clinicopathologic data from rectal cancer patients who underwent NCRT and radical resection at the Cancer Hospital, Chinese Academy of Medical Sciences/National Cancer Center (NCC) from January 2004 to December 2015, as well as patients diagnosed with rectal cancer who received neoadjuvant therapy followed by surgery in the Surveillance, Epidemiology, and End Results (SEER) database between January 2010 and December 2015. The optimal cutoff value for the number of examined LNs (ELNs) was determined using the X-tile software. Prognosis was assessed using the Kaplan-Meier method and log-rank test, while Cox regression analysis was employed to identify prognostic risk factors.
Results
A total of 6,634 patients were included, comprising 391 patients in the NCC cohort and 6,243 patients in the SEER cohort. In the NCC cohort, there was no significant survival difference between patients with
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Colorectal Surgery, National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, China.
- State Key Laboratory of Molecular Oncology, National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, China.
- Department of Pathology, National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, China.
- Department of Radiotherapy, National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, China.
Zitieren
APA
Xi, K., Feng, L., Xu, T., Zhang, L., Zhu, Y., Fang, H., & Zhang, H. (2025). The optimal number of lymph nodes examined for rectal cancer patients undergoing neoadjuvant long-course chemoradiotherapy. Journal of Gastrointestinal Oncology, 16(6), 2620-2631. https://doi.org/10.21037/jgo-2025-463
Vancouver
Xi K, Feng L, Xu T, Zhang L, Zhu Y, Fang H, et al. The optimal number of lymph nodes examined for rectal cancer patients undergoing neoadjuvant long-course chemoradiotherapy. Journal of Gastrointestinal Oncology. 2025;16(6):2620-2631. doi:10.21037/jgo-2025-463
BibTeX
@article{Xi2025,
author = {Xi, Kexing and Feng, Lin and Xu, Tianlei and Zhang, Lin and Zhu, Yuelu and Fang, Hui and Zhang, Haizeng},
title = {The optimal number of lymph nodes examined for rectal cancer patients undergoing neoadjuvant long-course chemoradiotherapy},
journal = {Journal of Gastrointestinal Oncology},
year = {2025},
volume = {16},
number = {6},
pages = {2620--2631},
doi = {10.21037/jgo-2025-463}
}
EUVIMED